prudentix ltd
General Data
Reg Number
515469005
Additional Funding
0
Description
Prudentix develops regenerative treatments for the dental (periodontal), orthopedic and dermal market. Our products are based on a novel component - rAmelX - a human recombinant protein amelogenin of which is a catalyst for natural cell regeneration
Winning details
Route name
Winning year
Development to manufactor
Development to manufactor
2023
Development to manufactor
Development to manufactor
2024